Paes, Lisvane Silva; Mantilla, Brian Suárez; Barisón, Maria Julia; Wrenger, Carsten 
; Silber, Ariel Mariano
Fonte: Current Pharmaceutical Design. Unidade: ICB
Assunto: PARASITOLOGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
PAES, Lisvane Silva et al. The uniqueness of the Trypanosoma cruzi mitochondrion: opportunities to target new drugs against chagas´ disease. Current Pharmaceutical Design, v. 17, n. 20, p. 2074-2099, 2011Tradução . . Disponível em: https://doi.org/10.2174/138161211796904786. Acesso em: 16 nov. 2025.APA
Paes, L. S., Mantilla, B. S., Barisón, M. J., Wrenger, C., & Silber, A. M. (2011). The uniqueness of the Trypanosoma cruzi mitochondrion: opportunities to target new drugs against chagas´ disease. Current Pharmaceutical Design, 17( 20), 2074-2099. doi:10.2174/138161211796904786NLM
Paes LS, Mantilla BS, Barisón MJ, Wrenger C, Silber AM. The uniqueness of the Trypanosoma cruzi mitochondrion: opportunities to target new drugs against chagas´ disease [Internet]. Current Pharmaceutical Design. 2011 ; 17( 20): 2074-2099.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/138161211796904786Vancouver
Paes LS, Mantilla BS, Barisón MJ, Wrenger C, Silber AM. The uniqueness of the Trypanosoma cruzi mitochondrion: opportunities to target new drugs against chagas´ disease [Internet]. Current Pharmaceutical Design. 2011 ; 17( 20): 2074-2099.[citado 2025 nov. 16 ] Available from: https://doi.org/10.2174/138161211796904786
